News

      November 30, 2022 Event

      Oblique Therapeutics is thrilled to take part to the next PLCF Event in France

      6th December 2022- Paris

      Read more

      November 23, 2022 Event

      Oblique Therapeutics is excited to be participating in the Biotechgate Digital Partnering event

      Nov 28 - Dec 2, 2022 a great opportunity to establish new global connections!

      Read more

      November 11, 2022 Event

      Oblique Therapeutics takes part to the 11th Drug Discovery Strategic Summit

      November 10th-11th 2022 - Amsterdam - Netherland

      Read more

      November 9, 2022 News

      Oblique Therapeutics is pleased to announce the nomination of Christer Nordstedt M.D. Ph.D. as Chief Executive Officer

      the new CEO will assume the position on 1st December 2022.

      Read more

      October 18, 2022 Event

      Oblique Therapeutics is looking forward to attend in-person the BIO Europe meeting October 24–26, 2022 | in Leipzig, Germany

      We will also take part to the Bio Europe Virtual Event November 2–4, 2022.

      Read more

      September 29, 2022 Event

      Oblique Therapeutics will be participating virtually in Bio Japan 2022

      on 12th-14th October

      Read more

      September 20, 2022 Event

      Oblique Therapeutics is attending next BioPharma America Boston

      next 28-29 September 2022 In-person and Virtual Oct 4-5 2022

      Read more

      August 25, 2022 Event

      Oblique Therapeutics will take part in the upcoming Biotechgate Digital Partnering

      Virtual business development & licensing event | Aug 29 - Sep 2, 2022

      Read more

      July 28, 2022 News

      REKRYTERING AV NY VD

      Read more

      July 8, 2022 News

      North Point Securities agerade finansiell rådgivare i samband med

      Oblique Therapeutics AB (publ.) Private Placement om cirka 28 MSEK.

      Read more
      1 2 3 6